Hijery ny anatiny

Bêta-thalassémie mineure et intermédiaire

Soins de soutien

Chélation du fer

Iron out for nontransfused thalassemia. (manokatra rohy)

Marks PW.

Loharanon-kevitra‎: Blood 2012;120(5):928-9.

Rakitra‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (manokatra rohy)

Iron overload in β-thalassemia intermedia: an emerging concern. (manokatra rohy)

Musallam KM, Cappellini MD, Taher AT.

Loharanon-kevitra‎: Curr Opin Hematol 2013;20(3):187-92.

Rakitra‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (manokatra rohy)

Compléments alimentaires et autres thérapies de soutien

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (manokatra rohy)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Loharanon-kevitra‎: Blood 2012;120(7):1531-2.

Rakitra‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (manokatra rohy)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (manokatra rohy)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Loharanon-kevitra‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Rakitra‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (manokatra rohy)

Therapeutic roles of curcumin: lessons learned from clinical trials. (manokatra rohy)

Gupta SC, Patchva S, Aggarwal BB.

Loharanon-kevitra‎: AAPS J 2013;15(1):195-218.

Rakitra‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (manokatra rohy)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (manokatra rohy)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Loharanon-kevitra‎: J Med Assoc Thai 2012;95(1):29-36.

Rakitra‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (manokatra rohy)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (manokatra rohy)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Loharanon-kevitra‎: Am J Hematol 2013;88(6):503-6.

Rakitra‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (manokatra rohy)